Home/Filings/4/0000950170-24-038097
4//SEC Filing

Wadhane Jitendra 4

Accession 0000950170-24-038097

CIK 0001782223other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:31 PM ET

Size

4.8 KB

Accession

0000950170-24-038097

Insider Transaction Report

Form 4
Period: 2024-03-26
Wadhane Jitendra
SVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2024-03-26+131,484398,421 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Documents

1 file

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001941706

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:31 PM ET
Size
4.8 KB